Synopsis
0
EU WC
0
VMF
0
FDF
0
FDA Orange Book
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Comhony Biotech manufactures fermentation & semi-synthetic APIs which aim at dermatology, anti-biotics; mitochondria & memory health.
Click Us!
Comhony Biotech manufactures fermentation & semi-synthetic APIs which aim at dermatology, anti-biotics; mitochondria & memory health.
CEP/COS 
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Fusidate Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fusidate Sodium, including repackagers and relabelers. The FDA regulates Fusidate Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fusidate Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fusidate Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fusidate Sodium supplier is an individual or a company that provides Fusidate Sodium active pharmaceutical ingredient (API) or Fusidate Sodium finished formulations upon request. The Fusidate Sodium suppliers may include Fusidate Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Fusidate Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fusidate Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Fusidate Sodium active pharmaceutical ingredient (API) in detail. Different forms of Fusidate Sodium DMFs exist exist since differing nations have different regulations, such as Fusidate Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fusidate Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Fusidate Sodium USDMF includes data on Fusidate Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fusidate Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fusidate Sodium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Fusidate Sodium Drug Master File in Japan (Fusidate Sodium JDMF) empowers Fusidate Sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Fusidate Sodium JDMF during the approval evaluation for pharmaceutical products. At the time of Fusidate Sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Fusidate Sodium suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Fusidate Sodium Drug Master File in Korea (Fusidate Sodium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Fusidate Sodium. The MFDS reviews the Fusidate Sodium KDMF as part of the drug registration process and uses the information provided in the Fusidate Sodium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Fusidate Sodium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Fusidate Sodium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Fusidate Sodium suppliers with KDMF on PharmaCompass.
A Fusidate Sodium CEP of the European Pharmacopoeia monograph is often referred to as a Fusidate Sodium Certificate of Suitability (COS). The purpose of a Fusidate Sodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Fusidate Sodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Fusidate Sodium to their clients by showing that a Fusidate Sodium CEP has been issued for it. The manufacturer submits a Fusidate Sodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Fusidate Sodium CEP holder for the record. Additionally, the data presented in the Fusidate Sodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Fusidate Sodium DMF.
A Fusidate Sodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Fusidate Sodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Fusidate Sodium suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fusidate Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fusidate Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fusidate Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fusidate Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fusidate Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fusidate Sodium suppliers with NDC on PharmaCompass.
Fusidate Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fusidate Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fusidate Sodium GMP manufacturer or Fusidate Sodium GMP API supplier for your needs.
A Fusidate Sodium CoA (Certificate of Analysis) is a formal document that attests to Fusidate Sodium's compliance with Fusidate Sodium specifications and serves as a tool for batch-level quality control.
Fusidate Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Fusidate Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fusidate Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Fusidate Sodium EP), Fusidate Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fusidate Sodium USP).
LOOKING FOR A SUPPLIER?
